AFJKR Company Profile and Key Details

Aimei Health Technology Co., Ltd (NASDAQ:AFJKR) closed at $0.15 USD, gaining $0.04 (36.24%) from the previous close of $0.11. The stock is currently trading near its 52-week high $0.11 and $0.15. With a market capitalization of about $1.10 million, Aimei Health Technology Co., Ltd is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.40). Key stats such as the average daily volume over the past year has been around 36.04 thousand shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, Aimei Health Technology Co., Ltd operates in the Financial Services sector and the Shell Companies industry. Led by CEO Junheng Xie, the company employs approximately 2 people and listed since December 01, 2023. Aimei Health Technology Co., Ltd presently has no significant ongoing business activities.

Average 10-day trading volume of 2.45 thousand shares is below the 3-month average of 43.48 thousand, indicating normal recent market interest.

Aimei Health Technology Co., Ltd last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.50. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Aimei Health Technology Co., Ltd stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Aimei Health Technology Co., Ltd trading at a premium to the broader market with a P/E of 179.62.

Aimei Health Technology Co., Ltd trades at a P/E ratio of 179.62, slightly above the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 1.59 suggesting the stock is closer to book value. The P/FCF stands at -104.59, also below market averages.